diabetic foot ulcer market report, diabetic foot ulcer market share, diabetic foot ulcer market reserch, diabetic foot ulcer market growth, diabetic foot ulcer market forecast, diabetic foot ulcer market scope
How much is the diabetic foot ulcer market worth, and how is it expected to expand?
The diabetic foot ulcer market size has grown strongly in recent years. It will grow from $5.84 billion in 2024 to $6.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing diabetes prevalence, aging population, improvements in wound care technologies, healthcare access and awareness.
The diabetic foot ulcer market size is expected to see strong growth in the next few years. It will grow to $8.41 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote monitoring, emerging markets expansion, advanced biomaterials. Major trends in the forecast period include digital health solutions, patient-centred care, collaborative care models, preventive care and education.
Get Your Free Sample of The Global Diabetic Foot Ulcer Market Report:
How has the diabetic foot ulcer market evolved, and what factors have shaped its growth?
The rising geriatric population is expected to propel the growth of the diabetic foot ulcer market going forward. The geriatric population refers to the segment of the elderly or older, typically aged 65 and older. Diabetic foot ulcers are a common and significant concern within the senior population. Elderly individuals with diabetes are particularly susceptible to foot ulcers due to neuropathy, reduced circulation and slower healing processes. For instance, in October 2022, according to reports shared by the World Health Organization, a US-based specialized health agency, globally, 1 in 6 individuals will be 60 or older by 2030 and by 2050, there will be a double amount of individuals in this age group (2.1 billion). Therefore, the rising geriatric population is driving the growth of the diabetic foot ulcer market.
What are the major segments of the diabetic foot ulcer market?
The diabetic foot ulcer market covered in this report is segmented –
1) By Type: Advanced Wound Care Dressings, Biologics, Therapy Device
2) By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers
3) By End-User: Hospitals, Ambulatory Surgery Centers, Home Care
Subsegments:
1) By Advanced Wound Care Dressings: Foam Dressings, Hydrocolloid Dressings, Alginate Dressings, Transparent Film Dressings, Antimicrobial Dressings
2) By Biologics: Skin Substitutes, Growth Factors, Human Tissue Allografts
3) By Therapy Device: Negative Pressure Wound Therapy Devices, Electrical Stimulation Devices, Hyperbaric Oxygen Therapy Devices
Order your report now for swift delivery
Which companies dominate the diabetic foot ulcer market?
Major companies operating in the diabetic foot ulcer market are Cardinal Health Inc., Johnson And Johnson Private Limited, 3M Company, Medtronic PLC, Medline Industries Inc., Coloplast A/S, B. Braun Melsungen AG, Nitto Denko Corporation, Smith and Nephew PLC, Human Biosciences Inc., Derma Sciences Inc., Convatec Inc., Molnlycke Health Care AB., Integra LifeSciences Corporation, Lohmann And Rauscher International GmbH and Co. KG, Acelity L.P. Inc., Pliant Therapeutics Inc., MiMedx Group, BSN Medical GMBH, Osiris Therapeutics Inc., Advanced Medical Solutions Group PLC, Organogenesis Inc., Healiance Inc., Misonix Inc., MediWound Ltd., Tissue Regenix Group Limited, Systagenix Wound Management Limited, Healios KK.
How will evolving trends contribute to the growth of the diabetic foot ulcer market?
Major companies operating in the diabetic foot ulcer market are focused on developing innovative products to meet the needs of their existing consumers. Innovative devices such as Theruptor Novo aim to improve outcomes for individuals with diabetic foot ulcers by enhancing wound care, monitoring and overall foot health. For instance, in October 2022, Healthium Medtech Limited, an India-based medical devices company, launched Theruptor Novo, an innovative device for treating diabetic foot ulcers (DFUs). It is a non-invasive, minimally invasive device that uses focused ultrasound to create microchannels in the skin and tissue surrounding the ulcer. These micro-channels allow for the delivery of oxygen and nutrients to the ulcer, which can help promote healing. Additionally, it has the potential to help patients heal their ulcers and avoid amputation.
What are the key regional dynamics of the diabetic foot ulcer market, and which region leads in market share?
North America was the largest region in the diabetic foot ulcer market in 2024. The regions covered in diabetic foot ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Diabetic Foot Ulcer Market Report 2025 Offer?
The diabetic foot ulcer market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Diabetic foot ulcers are open sores or wounds that commonly develop on the feet of individuals with diabetes. These ulcers are a severe and often chronic complication of diabetes, primarily due to the adverse effects of the disease on the circulatory and nervous systems. Diabetes food ulcer treatment is used to enhance blood sugar control and vascular therapies.
Purchase the exclusive report now to unlock valuable market insights:
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
